TY - JOUR
T1 - ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1
AU - Horn, Galit
AU - Gaziel, Avital
AU - Wreschner, Daniel H.
AU - Smorodinsky, Nechama I.
AU - Ehrlich, Marcelo
N1 - Funding Information:
Financial support: Israel Science Foundation Grant 1122/06 (ME); Israel Science Foundation Grant 398/03 (NIS); The Israeli Health Ministry Grant 6430-6 (NIS);The Ela Kodesz Institute for Research on Cancer Development and Prevention (ME and NIS); Alec and Myra Marmot (NIS).
PY - 2009/5/1
Y1 - 2009/5/1
N2 - Epithelial to mesenchymal transition (EMT) integrates changes to cell morphology and signaling pathways resulting from modifications to the cell's transcriptional response. Different combinations of stimuli ignite this process in the contexts of development or tumor progression. The human MUC1 gene encodes multiple alternatively spliced forms of a polymorphic oncoprotein that is aberrantly expressed in epithelial malignancies. MUC1 is endowed with various signaling modules and has the potential to mediate proliferative and morphological changes characteristic of the progression of epithelial tumors. The tyrosine-rich cytoplasmic domain and the heavily glycosylated extracellular domain both play a role in MUC1-mediated signal transduction. However, the attribution of function to specific domains of MUC1 is difficult due to the concomitant presence of multiple forms of the protein, which stem from alternative splicing and proteolytic cleavage. Here we show that DA3 mouse mammary tumor cells stably transfected with a truncated genomic fragment of human MUC1 undergo EMT. In their EMT, these cells demonstrate altered [i] morphology, [ii] signaling pathways and [iii] expression of epithelial and mesenchymal markers. Similarly to well characterized human breast cancer cell lines, cells transfected with truncated MUC1 show an ERK-dependent increased spreading on fibronectin, and a PI3K-dependent enhancement of their proliferative rate.
AB - Epithelial to mesenchymal transition (EMT) integrates changes to cell morphology and signaling pathways resulting from modifications to the cell's transcriptional response. Different combinations of stimuli ignite this process in the contexts of development or tumor progression. The human MUC1 gene encodes multiple alternatively spliced forms of a polymorphic oncoprotein that is aberrantly expressed in epithelial malignancies. MUC1 is endowed with various signaling modules and has the potential to mediate proliferative and morphological changes characteristic of the progression of epithelial tumors. The tyrosine-rich cytoplasmic domain and the heavily glycosylated extracellular domain both play a role in MUC1-mediated signal transduction. However, the attribution of function to specific domains of MUC1 is difficult due to the concomitant presence of multiple forms of the protein, which stem from alternative splicing and proteolytic cleavage. Here we show that DA3 mouse mammary tumor cells stably transfected with a truncated genomic fragment of human MUC1 undergo EMT. In their EMT, these cells demonstrate altered [i] morphology, [ii] signaling pathways and [iii] expression of epithelial and mesenchymal markers. Similarly to well characterized human breast cancer cell lines, cells transfected with truncated MUC1 show an ERK-dependent increased spreading on fibronectin, and a PI3K-dependent enhancement of their proliferative rate.
KW - Breast cancer
KW - EMT
KW - ERK
KW - MUC1
KW - Mammary tumor
KW - PI3K
UR - http://www.scopus.com/inward/record.url?scp=64049093492&partnerID=8YFLogxK
U2 - 10.1016/j.yexcr.2009.02.011
DO - 10.1016/j.yexcr.2009.02.011
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:64049093492
SN - 0014-4827
VL - 315
SP - 1490
EP - 1504
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 8
ER -